Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Pazliz 400mg Tablet
Manufacturer/Marketed By : KHANDELWAL LABORATORIES PVT LTD
$100.83 $81.47
Sidmex Inovia offers bulk export supply of Pazliz 400mg Tablet (PAZOPANIB) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.Documents, cold-chain shipping and tenders:...
PAZOPANIB
Active Pharmaceutical Ingredient
Pazliz 400mg Tablet
$100.83
$81.47
Sidmex Inovia offers bulk export supply of Pazliz 400mg Tablet (PAZOPANIB) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.
Documents, cold-chain shipping and tenders: see our Export FAQ.
Priority markets: United Arab Emirates, Brazil, Turkey, Singapore, Kenya, Somalia, Ghana, Saudi Arabia, Mauritius, Nigeria, Tanzania, Senegal, Democratic Republic of the Congo, Mali. We also export worldwide, including:
Middle East: Oman, Qatar, Kuwait, Bahrain, Iraq, Jordan, Lebanon, Yemen, Iran
Africa: Egypt, Algeria, Morocco, Libya, Burkina Faso, Côte d'Ivoire, Gambia, Rwanda, Ethiopia, Djibouti, South Africa, Zimbabwe
Asia: Sri Lanka, Bangladesh, Nepal, Maldives, Philippines, Vietnam, Laos, Malaysia, Thailand, Taiwan
CIS & Eastern Europe: Russia, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Serbia, Latvia, Tajikistan
Latin America & Caribbean: Mexico, Chile, Peru, Colombia, Bolivia, Venezuela
Europe & Other: Switzerland, United Kingdom, Canada
Related products we supply: Alburel 20 gm/100 ml Injection
Pazliz 400mg Tablet contains the active substance pazopanib. It is an antineoplastic drug that belongs to the class of tyrosine kinase inhibitors. Pazliz Tablet is primarily used in adults to treat advanced kidney cancer or cancer that has spread to other organs. It is also indicated for certain forms of soft-tissue sarcoma, a type of cancer that affects the supportive tissues of the body. Pazliz Tablet use is mainly focused on slowing down or stopping the growth and spread of cancer cells by blocking specific proteins involved in tumor development. This makes it an effective treatment option for patients with advanced cancers. The Pazliz 400mg Tablet price may vary depending on the pharmacy, brand availability, and location. Patients are advised to consult their healthcare provider for proper guidance before starting the treatment.
Active Pharmaceutical Ingredient
Uses
• Advanced renal cell carcinoma
• Advanced soft tissue sarcoma
Benefits
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Most Common Side Effects
• Heart problems
• Bleeding from the anus, mouth
• Hypothyroidism
• Interstitial lung disease
• Infections
Common Side Effects
• Hypertension
• Hair color change
• Increased glucose levels
• Decreased weight, decrease in appetite
• Diarrhea
• Nausea, vomiting
• Muscle and joint pain
• Headache
• Shortness of breath
• Tiredness
How To Use
Your doctor will decide the dose and duration of the treatment based on your disease condition, severity, and other factors. Take the tablets as prescribed by your doctor. Do not break, crush, or chew the tablets. Swallow the tablet whole with a glass of water. Do not take this medicine with food, as it affects the absorption of this medicine. Take Pazliz 400mg tablet at least two hours after a meal or one hour before a meal.
Safety Advice
• Breast Feeding: Breastfeeding is not recommended in patients taking Pazliz 400mg tablet because the medicine passes into the breast milk in small amounts and may harm your baby.
• Alcohol: It is unknown whether it is safe to consume alcohol when taking Pazliz 400mg tablet. Consult your doctor for more advice.
• Liver: Pazliz 400mg tablet is unsafe when administered in patients with severe liver diseases. Dose adjustments are necessary for moderate liver failure. Inform your physician if you have liver problems before initiating the therapy.
• Lungs: It is unknown whether Pazliz 400mg tablet can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
• Driving: Driving or operating heavy machinery is unsafe after taking Pazliz 400mg tablet because you may feel dizzy, drowsy, or have blurred vision.
• Pregnancy: Pazliz 400mg tablet is unsafe to administer in pregnant women because it may affect the fetus. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant. Using an effective birth control method during the treatment and for at least 2 weeks after your last dose is necessary.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.